Collegium Pharmaceutical
Collegium Receives FDA Approval for Xtampza™ ER
04.26.16
CANTON, Mass., April 26, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) approved Xtampza™ ER (oxycodone) extended-release (ER) capsules CII, a twice-daily, oxycodone medication for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Read Full Release
Bivarus Raises $2 Million to Fuel Expansion Following Strong Growth in 2015
03.19.16
DURHAM, N.C. (Business Wire) March, 2016 – Bivarus, a patient-centered analytics company working with healthcare organizations to measure and analyze the patient experience, announced today it raised $2 million in its oversubscribed round of funding. This latest financing was co-led by new investor Hatteras Venture Partners and existing investor Excelerate Health Ventures. In addition to local investors, Bivarus attracted new institutional investors from outside of the Raleigh/Durham region: NueCura Partners of Nashville, Tenn., and Boston Millennia Partners of Boston, Mass. Read Full Release
Collegium Pharmaceutical
Collegium Announces Publication of Data on the In Vitro Assessment of IV Abuse of Xtampza ER in Journal of Opioid Management
03.03.16
CANTON, Mass., March 03, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the publication of results from a laboratory-based extraction, injection and syringeability study for Xtampza® ER compared to other marketed opioid analgesics in peer-reviewed Journal of Opioid Management. The publication is titled, “In Vitro Assessment of the Potential for Abuse via the Intravenous Route of Oxycodone DETERx® Microspheres.” Read Full Release
Collegium Pharmaceutical
William Blair Initial Report on Collegium
02.19.16
Initiating Coverage With an Outperform Rating and $35 Price Target Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Posts Earnings Growth of 18 Percent
02.09.16
Danbury, Conn. (Feb. 9, 2016) — Odyssey Logistics & Technology Corporation (Odyssey) announced today that earnings grew 18 percent in 2015, continuing an eight year trend of consecutive double digit earnings growth. Holding a leadership position in complex verticals, with a focus on driving significant technology advancements and realizing operational efficiencies, has facilitated this growth. Read Full Release
Collegium Pharmaceutical
BMP Portfolio Company Collegium Announces Favorable Judgment by the District Court of Massachusetts
02.11.16
CANTON, Mass., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced that the District Court of Massachusetts issued an order for final judgment in favor of Collegium and against plaintiffs Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P., and Rhodes Technologies. The judgment relates to Purdue’s three Orange Book-listed patents asserted against Collegium that were the cause of the 30 month stay imposed on our New Drug Application for Xtampza™ ER... Read Full Release
MedAptus
Millennia Portfolio Company, MedAptus®, Announces Emerson Hospital Deploys MedAptus to Improve Charge Capture, Management Processes
10.27.15
MedAptus® announces Emerson Hospital has selected the company’s Pro Charge Capture technology for its inpatient medicine, pediatrics and behavioral health providers. These clinical end-users utilize the Pro solution while on rounds at both Emerson and Spaulding Rehabilitation Hospitals. Read Full Release
Boston Millennia Partners
Boston Millennia Partners Expands Venture Affiliate Program
10.15.15
Ed, Jeremy and Jim join the other distinguished members of our Venture Affiliate Program (VAP). The VAP supports the firm's business objectives, including deal sourcing and portfolio company support, and is comprised of senior executives who have had extensive relevant business and investing experience. Read Full Release
Collegium Pharmaceutical
Collegium Announces FDA Tentative Approval for Xtampza(TM) ER, a Novel Abuse-Deterrent Analgesic for Chronic Pain
11.09.15
Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announces that the United States Food and Drug Administration (FDA) has granted tentative approval to the Company's New Drug Application (NDA) for Xtampza™ ER (oxycodone) extended-release capsules. Read Full Release
Histogenics Corporation to Participate in Upcoming Scientific and Investor Conferences
10.01.15
WALTHAM, Mass., October 1, 2015 /GLOBE NEWSWIRE/ – Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced that Company Management will be participating in four upcoming conferences. Read Full Release
Avhana Health
Millennia Founders Fund Invests in Avhana Health
06.30.15
Boston Millennia's Founders Fund invests in the seed round of Avhana Health, a Maryland-based startup with a mission of developing the world's most robust clinical decision support platform. Read Full Release
Boston Millennia Partners
Liquidity Events Take Center Stage for Boston Millennia Partners Funds
03.03.15
2014 developed as a year of favorable exit events for several companies in the Boston Millennia Partners portfolio. We look back on the year and highlight the portfolio companies, CardioMEMS, Inc. Precision Dermatology, Inc. and PHT which produced over $130 million in cash returns for our partnerships. Read Full Release
MedAptus
Bon Secours Richmond Health System Selects MedAptus to Automate Hospitalist Coding and Billing
07.21.15
MedAptus® announces that Bon Secours Richmond Health System has implemented the company's Pro Charge Capture technology for its adult hospitalist and pediatric hospitalist intensivist providers that deliver care at St. Mary’s Hospital. Read Full Release
MedAptus
Millennia Portfolio Company, MedAptus, Announces Kentucky Medical Services Foundation Selects “Enroll Solution” to Improve Overall Processes
06.02.15
MedAptus® announced Kentucky Medical Services Foundation, Inc. (KMSF) has contracted for the company’s Enroll offering, powered by Newport Credentialing Solutions, the nation’s premier provider of cloud-based credentialing workflow software and IT enabled services. Read Full Release
MedAptus
Millennia Portfolio Company, MedAptus, Expands Analytics Solution for Deeper Revenue Cycle Insight
04.28.15
MedAptus announces the availability of its Premium Analytics solution as an add-on to its award-winning Charge Capture suite. Customers interested in broader analysis of data now have the option of the new Premium solution to augment what MedAptus already provides in its standard reporting module. Read Full Release
PAREXEL International
PAREXEL Announces Agreement to Acquire Quantum Solutions India
03.25.15
PAREXEL International Corporation announced today that the Company has signed a definitive agreement to acquire all of the business assets of privately-owned Quantum Solutions India (“QSI”), a leading provider of specialized pharmacovigilance services, based in Chandigarh, India. Read Full Release
MedAptus
Millennia Portfolio Company, MedAptus, Chosen by Maury Regional Medical Center to Improve Inpatient Coding, Billing Processes
03.24.15
MedAptus® announces that Maury Regional Medical Center has contracted for the company’s Professional Charge Capture (Pro) solution for deployment to Family Health Group, the physician business unit within the Maury hospital system. Read Full Release
Collegium Pharmaceutical
Boston Millennia Portfolio Company, Collegium Pharmaceutical Raises $50 million Financing
03.10.15
Collegium Pharmaceutical, Inc., today announced that it has raised a $50 million financing. Collegium plans to use the proceeds of this financing to advance its lead abuse-deterrent product candidate, Xtampza ER through potential FDA approval and commercial launch as well as to fund operational growth and other pipeline development programs. Read Full Release
PHT Corp
Boston Millennia Partners Portfolio Company, PHT Corporation, is Acquired by ERT
02.27.15
PHT Corporation (PHT), the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced today that they have signed a definitive agreement under which ERT will acquire PHT. Read Full Release
Odyssey Logistics & Technology
Boston Millennia Partners Portfolio Company, Odyseey Logistics & Technology’s Growth Featured on newstimes.com
02.12.15
Odyssey Logistics & Technology Corp., the Danbury shipping company growing at breakneck speed, is featured on newstimes.com Read Full Release